Zhejiang Hisoar Pharmaceutical Co Ltd (002099) — Free Cash Flow Generation Index
Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has a Free Cash Flow Generation Index of -0.07x as of September 2025. Free cash flow of CN¥-1.04 Million represents 0% of operating cash flow (CN¥15.48 Million). See working capital position of Zhejiang Hisoar Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Zhejiang Hisoar Pharmaceutical Co Ltd Free Cash Flow Generation Index (2004–2024)
Historical FCF Generation Index trend for Zhejiang Hisoar Pharmaceutical Co Ltd across 21 annual periods. Explore Zhejiang Hisoar Pharmaceutical Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Zhejiang Hisoar Pharmaceutical Co Ltd (2004–2024)
Year-by-year Free Cash Flow Generation Index for Zhejiang Hisoar Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 002099 company net worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.30x | CN¥52.73 Million | CN¥174.83 Million | CN¥122.11 Million | ▼ -17.1% |
| 2023 | 0.36x | CN¥87.46 Million | CN¥240.54 Million | CN¥153.08 Million | ▲ +166.7% |
| 2022 | -0.55x | CN¥-63.33 Million | CN¥116.09 Million | CN¥179.42 Million | ▲ +56.1% |
| 2021 | -1.24x | CN¥-127.20 Million | CN¥102.36 Million | CN¥229.56 Million | ▼ -244.3% |
| 2020 | 0.86x | CN¥459.69 Million | CN¥533.87 Million | CN¥74.18 Million | ▲ +16.7% |
| 2019 | 0.74x | CN¥451.76 Million | CN¥612.40 Million | CN¥160.64 Million | ▲ +9.0% |
| 2018 | 0.68x | CN¥535.67 Million | CN¥791.45 Million | CN¥255.78 Million | ▲ +250.0% |
| 2017 | -0.45x | CN¥-46.32 Million | CN¥102.68 Million | CN¥148.99 Million | ▼ -156.2% |
| 2016 | 0.80x | CN¥505.10 Million | CN¥629.42 Million | CN¥124.31 Million | ▲ +123.7% |
| 2015 | 0.36x | CN¥165.81 Million | CN¥462.16 Million | CN¥296.36 Million | ▲ +205.4% |
| 2014 | 0.12x | CN¥22.50 Million | CN¥191.56 Million | CN¥169.06 Million | ▲ +103.2% |
| 2013 | -3.63x | CN¥-220.94 Million | CN¥60.85 Million | CN¥281.79 Million | ▼ -166.7% |
| 2012 | -1.36x | CN¥-246.06 Million | CN¥180.73 Million | CN¥426.79 Million | ▼ -1.0% |
| 2011 | -1.35x | CN¥-124.91 Million | CN¥92.62 Million | CN¥217.52 Million | ▼ -809.6% |
| 2010 | 0.19x | CN¥34.37 Million | CN¥180.88 Million | CN¥146.51 Million | ▼ -58.3% |
| 2009 | 0.46x | CN¥44.78 Million | CN¥98.38 Million | CN¥53.60 Million | ▲ +123.3% |
| 2008 | -1.95x | CN¥-59.80 Million | CN¥30.61 Million | CN¥90.40 Million | ▼ -62.5% |
| 2007 | -1.20x | CN¥-61.47 Million | CN¥51.14 Million | CN¥112.61 Million | ▼ -82.7% |
| 2006 | -0.66x | CN¥-40.70 Million | CN¥61.88 Million | CN¥102.59 Million | ▲ +37.0% |
| 2005 | -1.04x | CN¥-37.67 Million | CN¥36.07 Million | CN¥73.74 Million | ▼ -24454.1% |
| 2004 | 0.00x | CN¥-180.15K | CN¥42.36 Million | CN¥42.54 Million | — |